MedPath

江苏永达药业有限公司

Ownership
-
Established
2003-01-03
Employees
-
Market Cap
-
Website
http://www.yongdachina.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Balofloxacin

Product Name
巴洛沙星
Approval Number
国药准字H20140041
Approval Date
Jun 10, 2019
NMPA

Gatifloxacin Hydrochloride

Product Name
盐酸加替沙星
Approval Number
国药准字H20080207
Approval Date
Apr 24, 2018
NMPA

Gatifloxacin

Product Name
加替沙星
Approval Number
国药准字H20070008
Approval Date
Aug 24, 2016
NMPA

Nateglinide

Approval Number
国药准字H20061121
Approval Date
Jul 8, 2016
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.